The Effects of Vaginal Ospemifene on Pelvic Organ Vascularity and Blood Flow in Postmenopausal Women

Trial Profile

The Effects of Vaginal Ospemifene on Pelvic Organ Vascularity and Blood Flow in Postmenopausal Women

Withdrawn prior to enrolment
Phase of Trial: Phase IV

Latest Information Update: 05 Dec 2014

At a glance

  • Drugs Ospemifene (Primary)
  • Indications Menopause
  • Focus Pharmacodynamics
  • Acronyms Osphena
  • Most Recent Events

    • 02 Dec 2014 Status changed from not yet recruiting to withdrawn prior to enrolment as reported by ClinicalTrial.gov record.
    • 22 Dec 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top